JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2017, 66(3):112-116 | DOI: 10.36290/csf.2017.018

The role of a hospital pharmacist in the management of asthma in Great Britain

Inka Sembol1, Božena Macešková2,*
1 York Teaching Hospital, Great Britain
2 Department of Applied Pharmacy, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Brno

The role of the pharmacist in the asthma management is well established. However, there is still a considerable number of patients with suboptimal asthma control affecting patients' quality of life and resulting in poor outcomes, morbidity and mortality. The aim was to identify patients' factors, explore the hospital pharmacist's role in the asthma management and identify any areas for improvement in Great Britain. Qualitative data collection was selected. Patient's case studies and semi-structured open interviews with the hospital multi-disciplinary team (MDT) were applied. Data were analysed and grouped into themes. Patient's case studies showed a variety in the patients' understanding of the pharmacist's role in their asthma management and similarly of the pharmacy services available to them. From the MDT interviews it emerged that communication across the secondary/primary care is lacking at times, and as a result new communication systems are being implemented. More research is needed into the asthma-patients' needs and expectations of pharmacy service. The hospital pharmacists are well placed to recognise asthma patients requiring pharmaceutical interventions and to provide medicines optimisation, across the primary/ secondary care settings. It was observed that the level of patient's involvement in their asthma was dependent on their interest in utilising asthma information and pharmacy services.

Keywords: asthma; asthma management; hospital pharmacist; secondary care; case studies; qualitative research

Received: January 23, 2017; Accepted: April 25, 2017; Published: March 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sembol I, Macešková B. The role of a hospital pharmacist in the management of asthma in Great Britain. Čes. slov. farm. 2017;66(3):112-116. doi: 10.36290/csf.2017.018.
Download citation

References

  1. Levy S. K., et al. Why asthma still kills: the National Review of Asthma Deaths. Confidential Enquiry report. London: Royal College of Physicians 2014.
  2. APPG. APPG on respiratory health: Report on Enquiry into Respiratory Deaths. 2014. https://www.asthma.org.uk/globalassets/campaigns/appg_respiratory_deaths_2014_online.pdf
  3. Partridge M. R., van der Molen T., Myrseth S. E., Busse W. W. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulmonary Medicine 2006; 6, 13. Go to original source... Go to PubMed...
  4. Price D., Fletcher M., van der Molen T. Asthma control and management in 8000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. Primary Care Respiratory Medicine 2014; 24, 14009. Go to original source... Go to PubMed...
  5. Rabe K. F., Vermeire P. A., Soriano J. B., Maier W. C. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. The European Respiratory Journal 2000; 16: 802-807. Go to original source... Go to PubMed...
  6. Demoly P., Annunziata K., Gubba E., Adamek L. Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years. European Respiratory Review 2012; 21: 66-74. Go to original source... Go to PubMed...
  7. GLOBAL ASTHMA NETWORK: The global asthma report. Auckland, New Zealand: 2014.
  8. European Respiratory Society - European Lung White Book 2013. http://www.erswhitebook.org/chapters/adult-asthma/
  9. ASTHMA UK: Health Advice. 2016. https://www.asthma.org.uk/advice/
  10. Walker R., Whittlesea C. Clinical Pharmacy and Therapeutics. 5th ed. London: Churchill Livingstone Elsevier 2012; 998 p.
  11. BRITISH THORACIC SOCIETY and SCOTTISH INTERCOLLEGIATE GUIDELINES NETWORK (BTS&SIGN): The British guideline on the management of asthma. A national clinical guideline SIGN 141.2014. https://www.brit-thoracic.org.uk/document-library/clinical-information/asthma/btssign-asthma-guideline-2014/
  12. Katzung B. G., Masters S. B., Trevor A. J. Basic and Clinical Pharmacology, 14th ed. McGraw Hill, Lange 2016; 1310 p.
  13. Khachi H., Meynell H., Murphy A. Asthma: Long-term management. Clinical Pharmacist. 2014; 9, 225-228.
  14. D'Ancone G. Inhaled corticosteroids: managing side effects. The Pharmaceutical Journal 2015; 294(7851), 247-249.
  15. Kerstjens H. A. M., et al. Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallelgroup, active-comparator, randomised trials. Lancet 2015; 3(5), 367-376. Go to original source... Go to PubMed...
  16. Murphy A. Asthma: treatment and monitoring. Clinical Pharmacist 2010; 2, 209-214.
  17. Papi A., et al. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial. Lancet 2013; 1(1), 23-31. Go to original source... Go to PubMed...
  18. Patel M., et al. Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial. Lancet 2013; 1(1), 32-42. Go to original source... Go to PubMed...
  19. Thomson N. Recent advances in the treatment and management of asthma. The Prescriber 2015; 19, 17-24. Go to original source...
  20. NICE: Quality standards for asthma. 2013. http://www.nice.org.uk/guidance/qs25
  21. Dominguez-Ortega J., et al. Cost-effectiveness of asthma therapy: A Comprehensive review. Journal of Asthma 2014; 52(6), 1-23. Go to original source... Go to PubMed...
  22. DiCicco-Bloom B., Crabtree B. F. The qualitative research interview. Medical Education 2002; 40(4), 314-321. Go to original source... Go to PubMed...
  23. Babar Z. Pharmacy Practice Research Methods. London: Springer International Publishing AG 2015; 251 p. Go to original source...
  24. Fathima M., et al. The role of community pharmacists in screening and subsequent management of chronic respiratory diseases: a systematic review. Pharmacy practice 2013; 11(4), 228-245. Go to original source... Go to PubMed...
  25. Adunlin G., et al. The Effectiveness of Pharmacist Interventions on Asthma Management: a systematic review. Journal of asthma and allergy educators 2012; 3(6), 264-273. Go to original source...
  26. Peytremann- Bridevaux I., et al. Chronic disease management programmes for adults with asthma. Cochrane Database of Systematic Reviews. 2015. Issue 5. Go to original source...
  27. RPS Clinical Governance. 2016. http://www.rpharms.com/support-resources-a-z/clinical-governance-quick-reference-guide.asp
  28. BRITISH LUNG FOUNDATION Asthma 2016. https://www.blf.org.uk/support-for-you/asthma
  29. GPhC Standards of conduct, ethics and performance 2012. https://www.pharmacyregulation.org/sites/default/files/standards_of_conduct_ethics_and_performance_july_2014.pdf
  30. NICE: Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes 2015. https://www.nice.org.uk/guidance/ng5
  31. NICE: Patient experience in adult NHS services: improving the experience of care for people using adult NHS services. Clinical Guideline 138, 2012. https://www.nice.org.uk/guidance/cg138
  32. NHS England: Confidentiality Policy 2014. https://www.england.nhs.uk/wp-content/uploads/2013/06/conf-policy-1.pdf
  33. Department of Health: Equity and excellence: Liberating the NHS 2010. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/@ps/documents/digitalasset/dh_117794.pdf
  34. GENERAL MEDICAL COUNCIL: The Good Medical Practice. 2014. http://www.gmc-uk.org/guidance/good_medical_practice.asp
  35. NHS England. Confidentiality: The NHS Code of Practice 2003. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/200146/Confidentiality_-_NHS_Code_of_Practice.pdf
  36. JuniperE. F., et al. Development and validation of the Mini Asthma Quality of Life Questionnaire. The European Respiratory Journal 1999; 14(1), 32-38. Go to original source... Go to PubMed...
  37. Millard M., Hart M., Barnes S. Validation of Rules of Two ™ as a paradigm for assessing asthma control. Proceedings (Baylor University Medical Centre) 2014; 27(2), 79-82. Go to original source...
  38. Gurkova E., Popelkova P. Validity of Asthma Control Test in Assessing Asthma Control in Czech Outpatient Setting. Central European Journal of Public Health 2015; 23(4), 286-291. Go to original source... Go to PubMed...
  39. Naik-Panvelkar P., et al. A pharmacy asthma service achieves a change in patient responses from increased awareness to taking responsibility for their asthma. The International journal of pharmacy practice 2015; 23(3), 182-191. Go to original source... Go to PubMed...
  40. Pinnock H., et al. Systematic meta-review of supported self-management for asthma: a healthcare perspective. BMC Medicine 2017; 15(64), 1-32. Go to original source... Go to PubMed...
  41. Lingner H., et al. What patients really think about asthma guidelines: barriers to guideline implementation from the patients' perspective. BMC Pulmonary Medicine 2017; 17(13), 1-12. Go to original source... Go to PubMed...
  42. Peláez S., et al. Patients' perspective of barriers and facilitators to taking long-term controller medication for asthma: a novel taxonomy. BMC Pulmonary Medicine 2015; 15(42), 1-11. Go to original source... Go to PubMed...
  43. Macešková B., Fridrichová D. Monitorování terapie astmatických pacientů v lékárně. Klinická farmakologie a farmacie 2005; 19: 206-210.




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.